GPD2 Antibodies

Santa Cruz Biotechnology offers a broad range of GPD2 monoclonal antibodies for research focused on glycerol-3-phosphate dehydrogenase 2 (GPD2) functions. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GPD2 plays a crucial role in cellular metabolism by catalyzing the conversion of glycerol-3-phosphate to dihydroxyacetone phosphate, linking lipid and carbohydrate metabolism. The enzyme maintains energy homeostasis and has significant implications in various metabolic disorders. Research has shown that GPD2 activity influences cellular energy balance and metabolic regulation. Understanding GPD2 function can provide insights into diseases such as obesity and diabetes. Investigating GPD2 expression patterns helps reveal its distribution across different tissues and cell types. Current research continues to uncover new aspects of GPD2's involvement in metabolic pathways and disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies for GPD2 enable researchers worldwide to advance scientific understanding of metabolic diseases and potential therapeutic approaches.